eujobs.coEU jobs in brussels
Post a JobHeadhunter

Novavax

General Information

Identification Code: 334922247628-17
Website: [object Object]
Entity Form: Delaware Corporation
Registration Category: Companies & groups
Registration Date: 9/14/2022
Last Update: 6/27/2024
EP Accredited Number: 3

Mission & Interests

Goals: Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Our proprietary recombinant technology platform harnesses the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. To learn more, please visit www.novavax.com
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Business and industry
  • Digital economy and society
  • Public health
  • Research and innovation
  • Trade
Levels of Interest:
  • global
  • national
  • sub-national
  • european

Activities

Main EU Legislative Proposals: Novavax regularly interacts with the EU institutions and engages on issues relevant to the company, including the fight against COVID-19, pandemic preparedness, vaccination and the promotion of policies supporting global health. Key policies and initiatives include: EU vaccines strategy and policy, the review of the general pharmaceutical legislation, and the work of the European Health Emergency Preparedness and Response Authority.
Communication Activities: We regularly respond to relevant EU consultations.
Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: 21 Firstfield Road
Post Code: 20878
City: Gaithersburg
Country: UNITED STATES
Phone: [object Object]

EU Office

Address: Square de Meeûs, 37
Post Code: 1000
City: Brussels
Country: BELGIUM
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]

Membership Information

Members10 Percent: 0
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 2
Members F T E: 1.25

Structure

Structure Type: Structure
Is Member Of: none
Organisation Members: Vaccines Europe and the International Federation of Pharmaceutical Manufacturers and Associations